Vir Biotechnology (VIR) shares were 58% higher pre-bell Tuesday after the company said late Monday it partnered with Astellas Pharma to jointly advance the development and commercialization of VIR-5500 for the treatment of prostate cancer.
Myriad Genetics (MYGN) stock was up 19%, a day after the company reported higher Q4 adjusted earnings.
Super Group (SGHC) shares were 16% higher after the company reported late Monday higher Q4 revenue.
Thermon Group (THR) stock was up 16% after the company said it has agreed to merge with CECO Environmental (CECO) in a deal worth roughly $2.20 billion.